Target intelligence / Profile preview

Hydin axonemal central pair apparatus protein (HYDIN)

Target
HYDIN
Molecular classification
Axonemal/ciliary structural protein, Flagellar protein, Microtubule-associated protein
01

Overview

Hydin axonemal central pair apparatus protein (HYDIN) is a highly conserved structural protein essential for the assembly and function of the central pair apparatus in cilia and flagella. HYDIN localizes to the C2 microtubule within the central pair and is required for proper flagellar and ciliary motility; it participates in the regulation of dynein arm activity and bending of cilia/flagella. Loss-of-function mutations lead to structural defects in the central pair, impaired motility, and neurodevelopmental diseases such as hydrocephalus. HYDIN has multiple ASH (ASPM, SPD-2, Hydin) domains potentially involved in microtubule binding, and interacts with other central pair proteins including CPC1 and KLP1, anchoring components within the axoneme. Humans possess a duplicate, HYDIN2, expressed as alternatively spliced forms. HYDIN is not currently regarded as a therapeutic target, and no approved drugs or investigational agents act on HYDIN directly. While PPP1R31 is listed among aliases, there is no clear evidence that HYDIN acts as a classical regulatory subunit of protein phosphatase 1 in the context of human axonemal protein biology; the key roles, functional domains, and disease associations point to its principal structural function in cilia/flagella.

Other names
Hydrocephalus-inducing protein homologHYDIN1KIAA1864DKFZp434D0513PPP1R31CILD5Protein phosphatase 1, regulatory subunit 31HYDIN2
02

Mechanism of action

Not applicable; there are no drugs targeting HYDIN, so there is no mechanism of action to specify

03

Biological functions

Ciliary and flagellar motility: Essential for the proper movement of cilia and flagellaCentral pair apparatus formation and regulation: Contributes to the structural integrity and regulatory signaling inside the axoneme (core of cilia/flagella)Dynein arm activity regulation: Participates in the control pathway for dynein-driven bending
04

Disease associations

Neurodevelopmental/structural: Mutations cause hydrocephalus in mice (and candidate for primary ciliary dyskinesia and hydrocephalus in humans)Other cilia-related disorders (potential involvement)
05

Safety considerations

None documented for therapeutic targeting; as HYDIN is not druggable, no drug-related safety profile exists
06

Biomarkers

None specific; HYDIN mutation or expression status may potentially be investigated in research contexts related to hydrocephalus, but is not a clinical biomarker

Beyond the preview

Go deeper on Hydin axonemal central pair apparatus protein (HYDIN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydin axonemal central pair apparatus protein (HYDIN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call